| Literature DB >> 21223580 |
Charlotte A Jones1, Shefina Mawani, Kathryn M King, Selina Omar Allu, Megan Smith, Sailesh Mohan, Norman R C Campbell.
Abstract
BACKGROUND: Indo-Asians in Canada are at increased risk for cardiovascular diseases. There is a need for cultural and language specific educational materials relating to this risk. During this project we developed and field tested the acceptability of a hypertension public education pamphlet tailored to fit the needs of an at risk local Indo-Asian population, in Calgary, Alberta, Canada.Entities:
Mesh:
Year: 2011 PMID: 21223580 PMCID: PMC3030537 DOI: 10.1186/1471-2458-11-24
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Adapted English version pamphlet questionnaire and responses.
| Did you read the pamphlet? |
|---|
| Yes N = 59 No N = 3 |
| • |
| • |
| • No response |
| Yes = 56 (94.9%)* No = 3 (5.1%) |
| Yes = 8 (13.6) No = 51 (86.4%) |
| • |
| • |
| • |
| Yes = 53 (89.8%) No = 6 (10.2%) |
| Yes = 3 (5.1%) No = 56 (94.9%) |
| • |
| • |
| • N = 18 Gujarati ((30.5%), N = 3 Dari ((5.1%), N = 2 French ((3.4%), N = 1 Urdu (1.7%). |
| • " |
| • |
| • |
| • |
| • |
* Percents are based on the numbers of participants that read the pamphlet (N = 59)
Translated version questionnaire and responses
| Did you read the pamphlet? |
|---|
| Yes N = 30 No N = 5 No response N = 2 |
| • |
| • |
| • |
| No response N = 30 (100%) |
| Yes N = 30 (100%) |
| Yes N = 28 (93.3%) No N = 1 (3.3%) No response N =1 (3.3%). |
| • " |
| • |
| • |
| • |
| • |
| • |
| • |
| • |
| • |
| No response N = 6 (20.0%) |
* Percent based on the number of participants that read the pamphlet (N = 30).
Demographic and CVD risk factor profiles of participants who read and evaluated the materials.
| Demographics | English Version (N = 59) N (%) | Translated Version (N = 30) N (%) |
|---|---|---|
| Female | 26 (44) | 16 (57) |
| Age (Mean in years [range]) | 60.6 (46-79) | 69.1 (50-89) |
| | ||
| Reported history coronary heart disease | 4 (7.0) | 2 (6.0) |
| Reported HBP or related medication use** | 27 (45.8) | 17 (56.7) |
| Reported dyslipidemia or related medication use ≠ | 34 (57.6) | 13 (43.3) |
| Reported diabetes or related medication use | 10 (5.9) | 9 (30.0) |
| Reported family history of CVD | 23 (39.0) | 6 (20.0) |
| Measured BP above target+ at program entry | 16 (27.1) | 14 (46.6) |
| Measured cholesterol above target ++ | 39 (66.0)* | 13 (43.3) † |
| Identified as 'high risk' | 38 (64.4)* | 21 (70.0) † |
± Significantly (P < 0.05) older than Group one (Z-Test).* Cholesterol and risk level measurements not completed for 3 participants.† Cholesterol and risk level measurements not completed for 5 participants. **, ≠ As diagnosed by a health care professional. + (>140/90 mmHg and 130/80 mmHg (in those with diabetes). ++ TC/HDL > 4 for high risk and > 6 for low/moderate risk participants.